Physician profile
Long Duc Tran
NPI 1306895024
$2,757.11
in general payments reported to CMS, 2019-2025
34 companies · $681 in 2025
The $681 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $650 · 2020: $141 · 2021: $68.51 · 2022: $363 · 2023: $557 · 2024: $296 · 2025: $681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,531 · Education: $2.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,530.81 |
| Education | $2.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $584.04 | 2019-2025 | Farxiga, Lokelma |
| Amgen INC. | $254.44 | 2023-2025 | Tavneos, Krystexxa |
| Akebia Therapeutics INC | $150.45 | 2019-2020 | |
| Novo Nordisk INC | $143.35 | 2022-2025 | Ozempic, Rybelsus |
| Vifor Pharma, INC. | $125.32 | 2019-2023 | Veltassa |
| Opko Pharmaceuticals, LLC | $120.87 | 2019-2025 | Rayaldee |
| Glaxosmithkline, LLC. | $114.99 | 2022-2024 | Benlysta |
| Mallinckrodt Hospital Products INC. | $112.73 | 2020-2023 | Acthar |
| Otsuka America Pharmaceutical, INC. | $108.43 | 2019-2025 | Jynarque |
| Horizon Therapeutics Plc | $94.14 | 2023 | Krystexxa |
| Fresenius USA Marketing, INC. | $87.28 | 2022-2025 | Velphoro |
| Scpharmaceuticals INC. | $85.04 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $73.75 | 2023-2025 | |
| Shire North American Group INC | $65.42 | 2019 | |
| La Jolla Pharmaceutical Company | $63.22 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $56.28 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.67 | 2024-2025 | Jardiance |
| Alexion Pharmaceuticals, INC. | $46.53 | 2023 | Ultomiris |
| Janssen Pharmaceuticals, INC | $45.96 | 2019-2021 | |
| Aurinia Pharma U.S., INC. | $41.61 | 2024 | Lupkynis |
| Calliditas Therapeutics US INC. | $36.43 | 2025 | Tarpeyo |
| Genentech USA, INC. | $33.28 | 2019 | |
| Nxstage Medical, INC. | $31.16 | 2022 | |
| Ardelyx, INC. | $27.55 | 2025 | Ibsrela |
| Ani Pharmaceuticals, INC. | $24.85 | 2023 | Purified Cortrophin Gel |
| Melinta Therapeutics, LLC | $24.70 | 2019 | |
| Genzyme Corporation | $24.46 | 2019 | |
| Veloxis Pharmaceuticals, INC. | $22.63 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.23 | 2024 | Livtencity |
| Mallinckrodt Enterprises LLC | $19.91 | 2019 | |
| Lilly USA, LLC | $18.97 | 2025 | Jardiance |
| Smith+Nephew, INC. | $14.77 | 2024 | Oasis, Grafix Pl |
| Chiesi USA, INC. | $14.38 | 2019 | |
| Getinge USA Sales, LLC | $14.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Long Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.